SUMMARY OF BASIC LEASE INFORMATIONExtension Option Rider • March 2nd, 2020 • Fate Therapeutics Inc • Biological products, (no disgnostic substances)
This Lease, which includes the preceding Summary and the exhibits attached hereto and incorporated herein by this reference (the Lease, the Summary and the exhibits to be known sometimes collectively hereafter as the “Lease”), dated as of the date set forth in Section 1 of the Summary, is made by and between SCRIPPS SUMMIT INVESTMENTS LLC, a California limited liability company (“Landlord”), and FATE THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
